The collaborators are developing tests for rectal cancer based on microRNA and messenger RNA signatures.
The consortium aims to profile up to 800 multiple myeloma patient samples using the Affymetrix platform with a goal of developing a list of predictive biomarkers.
The European Commission may exempt researchers from a copyright law to enable data mining, according to Nature News.
Interviews with leading UK scientists revealed apprehension about losing access to European funding, limitations on freedom of movement, and an exodus of biotechs to the EU.
The European Commission recently awarded the researchers €1.5 million to probe the mechanics of heart failure using proteomic, genomic, and epidemiological approaches.
Questions remain about how the €6.7 billion ($7.6 billion) pledged for the implementation of the European Open Science Cloud over the next four years will be spent.
Researchers plan to develop a device that supports nucleic acid sequencing and protein sequencing using plasmonic nanostructures.
Called the European Open Science Cloud, the initiative is designed to support the storage, sharing, and use of scientific and technological research data.
As part of the effort, Virus.X also aims to craft new sequencing approaches, bioinformatics tools, and targeted gene products.
The European precision medicine project will use Agendia technology to subtype tumors and match patients with targeted therapies.
In Science this week: genetic target for urothelial bladder cancer treatment, and more.
At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.
Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.
Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.